BR9916417A - Triazineone compounds for the treatment of diseases due to sarcosystis, neospora and toxoplasma - Google Patents
Triazineone compounds for the treatment of diseases due to sarcosystis, neospora and toxoplasmaInfo
- Publication number
- BR9916417A BR9916417A BR9916417-5A BR9916417A BR9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- sarcosystis
- neospora
- toxoplasma
- compounds
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 241001147660 Neospora Species 0.000 title abstract 2
- 241000223996 Toxoplasma Species 0.000 title abstract 2
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 201000005485 Toxoplasmosis Diseases 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 230000002036 metaphylactic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: "COMPOSTOS TRIAZINAONA PARA TRATAMENTO DE DOENçAS DEVIDAS A SARCOSYSTIS, NEOSPORA E TOXOPLASMA". Descreve-se aqui um método de tratamento terapêutico ou metafilático de animais infectados susceptíveis de doenças parasitádas neurológicas ou abortíferas, ou já infectados com estas, doenças tais como Sarcocystidiae ou Toxoplasmose, tratáveis com compostos triazinaona, administrando-se a eles, uma quantidade farmaceuticamente eficaz, incluindo-se um tratamento terapêutico de dose única elevada.Invention Patent: "TRIAZINAONE COMPOUNDS FOR TREATING DISEASES DUE TO SARCOSYSTIS, NEOSPORA AND TOXOPLASMA". We describe here a method of therapeutic or metaphylactic treatment of infected animals susceptible to parasitic neurological or abortion diseases, or already infected with these, diseases such as Sarcocystidiae or Toxoplasmosis, treatable with triazinaone compounds, administering to them, a pharmaceutically effective amount , including a high single dose therapeutic treatment.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21871298A | 1998-12-22 | 1998-12-22 | |
| PCT/US1999/030284 WO2000037084A1 (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916417A true BR9916417A (en) | 2001-11-06 |
Family
ID=22816194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916417-5A BR9916417A (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for the treatment of diseases due to sarcosystis, neospora and toxoplasma |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1140101A1 (en) |
| JP (1) | JP2002532552A (en) |
| KR (1) | KR20010080571A (en) |
| CN (1) | CN1331595A (en) |
| AU (1) | AU2198100A (en) |
| BR (1) | BR9916417A (en) |
| CA (1) | CA2356181A1 (en) |
| HK (1) | HK1043065A1 (en) |
| HU (1) | HUP0104716A3 (en) |
| NZ (1) | NZ512476A (en) |
| WO (1) | WO2000037084A1 (en) |
| ZA (1) | ZA200103919B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9914385A (en) | 1998-10-08 | 2001-07-17 | New Ace Res Company | Useful composition for the treatment and prevention of protozoal infections in man and animals, and method of treating a protozoan infection in man and animals |
| DE19958388A1 (en) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinone compounds for the treatment of infestations with parasitic protozoa-related diseases |
| DE10040174A1 (en) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
| DE10040110A1 (en) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Use of triazinetrione sulfoxides to combat coccidioses |
| DE102007025908A1 (en) * | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulations containing triazinones and iron |
| DE102009012423A1 (en) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Preparation based on oil |
| CN102973497A (en) * | 2012-12-13 | 2013-03-20 | 江苏恒丰强生物技术有限公司 | Toltrazuril solution and preparation method thereof |
| WO2019162702A1 (en) | 2018-02-26 | 2019-08-29 | AlzeCure Pharma AB | Triazine derivatives for treating diseases relating to neurotrophins |
| GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2285477C (en) * | 1997-03-31 | 2006-10-10 | The University Of Kentucky Research Foundation | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
-
1999
- 1999-12-17 CN CN99815013A patent/CN1331595A/en active Pending
- 1999-12-17 KR KR1020017006550A patent/KR20010080571A/en not_active Application Discontinuation
- 1999-12-17 BR BR9916417-5A patent/BR9916417A/en not_active IP Right Cessation
- 1999-12-17 HU HU0104716A patent/HUP0104716A3/en unknown
- 1999-12-17 JP JP2000589195A patent/JP2002532552A/en active Pending
- 1999-12-17 EP EP99966449A patent/EP1140101A1/en not_active Withdrawn
- 1999-12-17 WO PCT/US1999/030284 patent/WO2000037084A1/en not_active Application Discontinuation
- 1999-12-17 CA CA002356181A patent/CA2356181A1/en not_active Abandoned
- 1999-12-17 NZ NZ512476A patent/NZ512476A/en unknown
- 1999-12-17 AU AU21981/00A patent/AU2198100A/en not_active Abandoned
-
2001
- 2001-05-15 ZA ZA200103919A patent/ZA200103919B/en unknown
-
2002
- 2002-07-05 HK HK02105041.6A patent/HK1043065A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1140101A1 (en) | 2001-10-10 |
| CA2356181A1 (en) | 2000-06-29 |
| WO2000037084A1 (en) | 2000-06-29 |
| HUP0104716A3 (en) | 2003-10-28 |
| KR20010080571A (en) | 2001-08-22 |
| NZ512476A (en) | 2003-08-29 |
| CN1331595A (en) | 2002-01-16 |
| HUP0104716A2 (en) | 2002-04-29 |
| HK1043065A1 (en) | 2002-09-06 |
| JP2002532552A (en) | 2002-10-02 |
| ZA200103919B (en) | 2002-05-15 |
| AU2198100A (en) | 2000-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2018C038I2 (en) | ||
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| Kaji et al. | Effect of ultrahigh‐dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: A double‐blind controlled study | |
| ATE334668T1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES | |
| BR0317747A (en) | Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer's disease and mild cognitive impairment | |
| RU94045155A (en) | Methods of alzheimer's disease inhibition | |
| BR9708114A (en) | Xanthone analogues for the treatment of infectious diseases. | |
| DE60036456D1 (en) | ANTIMICROBIAL EFFECTIVE OR ENDOTOXIN NEUTRALIZING POLYPEPTIDE | |
| DE602004031163D1 (en) | Phenylcarboxamide compounds for pain treatment | |
| BR9911094A (en) | Compositions and methods for the treatment of bone | |
| PT1140102E (en) | TRIAZINONE COMPOUNDS FOR TREATING DISEASES CAUSED BY SARCOSYSTIS, NEOSPORA ETOXOPLASMA | |
| BR9916417A (en) | Triazineone compounds for the treatment of diseases due to sarcosystis, neospora and toxoplasma | |
| BR9604973A (en) | A pharmaceutical composition containing n-chlorine phenyl carbamates and n-chlorine phenyl thiocarbamates for inhibiting the growth of viruses and cancers | |
| BR9815070A (en) | Compounds having an inhibitory effect of cgmp-pde | |
| BR9916391A (en) | Triazineone compounds for the treatment of diseases caused by sarcosiste, neopora and toxoplasma | |
| BR0210401A (en) | Compound, pharmaceutical composition, use of a compound and method for treating a disorder or disease of a living animal body, including a human | |
| HUP0000110A2 (en) | Pharmaceutical compositions comprising azacyclic, azabicyclic or tetrahydro-pyridine-derivatives suitable for treating pain | |
| BR0015781A (en) | Pharmaceutical composition for treatment of diseases associated with decreased bone mass | |
| YU60199A (en) | New bpc peptide salts with organo-protective activity,the process for their preparation and their use in therapy | |
| BR0308911A (en) | Compound, pharmaceutical composition, pain and migraine treatment methods, and use of a compound | |
| HUP0302330A2 (en) | Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora | |
| BR0210407A (en) | Compound, pharmaceutical composition, use of a compound and method of treating a living animal body disorder or disease, including a human | |
| SE9803623D0 (en) | New therapeutic application | |
| SI0872239T1 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
| BR0002260A (en) | Methods and compositions for the treatment of age-related disorders in pet animals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O E 7O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |